SOX9 and osteosarcoma: Last but not least, He et al. firstly generated a patient-derived organoid platform for lung metastatic osteosarcoma that preserved the cellular morphology and expression of the osteosarcoma markers Vimentin and SRY-Box Transcription Factor 9 (Sox9).